Cite
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases.
MLA
Gupta, Sudhir, et al. “Tolerability of Ig20Gly during Onboarding in Patients with Primary Immunodeficiency Diseases.” Annals of Allergy, Asthma & Immunology, vol. 123, no. 3, Sept. 2019, p. 271. EBSCOhost, https://doi.org/10.1016/j.anai.2019.06.004.
APA
Gupta, S., Stein, M., Hussain, I., Paris, K., Engl, W., McCoy, B., Rabbat, C. J., & Yel, L. (2019). Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases. Annals of Allergy, Asthma & Immunology, 123(3), 271. https://doi.org/10.1016/j.anai.2019.06.004
Chicago
Gupta, Sudhir, Mark Stein, Iftikhar Hussain, Kenneth Paris, Werner Engl, Barbara McCoy, Christopher J. Rabbat, and Leman Yel. 2019. “Tolerability of Ig20Gly during Onboarding in Patients with Primary Immunodeficiency Diseases.” Annals of Allergy, Asthma & Immunology 123 (3): 271. doi:10.1016/j.anai.2019.06.004.